Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients. | Int J Mol Sci | 2022 | 35409074 | PubTator, text mining | PubMed |
| Environmental Phenol and Paraben Exposure Risks and Their Potential Influence on the Gene Expression Involved in the Prognosis of Prostate Cancer. | Int J Mol Sci | 2022 | 35409038 | PubTator, text mining | PubMed |
| Comparison of the Cisterna Maturation-Progression Model with the Kiss-and-Run Model of Intra-Golgi Transport: Role of Cisternal Pores and Cargo Domains. | Int J Mol Sci | 2022 | 35408951 | PubTator, text mining | PubMed |
| Mucosal Immune Responses to Respiratory Syncytial Virus. | Cells | 2022 | 35406717 | PubTator, text mining | PubMed |
| Imaging Unique DNA Sequences in Individual Cells Using a CRISPR-Cas9-Based, Split Luciferase Biosensor. | Front Genome Ed | 2022 | 35403097 | PubTator, text mining | PubMed |
| Extracellular Matrix-Based Gene Expression Signature Defines Two Prognostic Subtypes of Hepatocellular Carcinoma With Different Immune Microenvironment Characteristics. | Front Mol Biosci | 2022 | 35402515 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Papillary Renal Cell Carcinoma. | Front Mol Biosci | 2022 | 35402508 | PubTator, text mining | PubMed |
| Molecular profiling of gene fusions in soft tissue sarcomas by Ion AmpliSeqTM: a study of 35 cases. | Transl Cancer Res | 2022 | 35402176 | PubTator, text mining | PubMed |
| CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types. | Oxid Med Cell Longev | 2022 | 35401923 | PubTator, text mining | PubMed |
| Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment. | Front Immunol | 2022 | 35392073 | PubTator, text mining | PubMed |
| CRISPR-mediated multiplexed live cell imaging of nonrepetitive genomic loci with one guide RNA per locus. | Nat Commun | 2022 | 35387989 | PubTator, text mining | PubMed |
| Multi-site desmoplastic small round cell tumors are genetically related and immune-cold. | NPJ Precis Oncol | 2022 | 35379887 | PubTator, text mining | PubMed |
| The Mechanism Underlying the Influence of Indole-3-Propionic Acid: A Relevance to Metabolic Disorders. | Front Endocrinol (Lausanne) | 2022 | 35370963 | PubTator, text mining | PubMed |
| Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma. | Int J Genomics | 2022 | 35359580 | PubTator, text mining | PubMed |
| Progress of CRISPR-Cas13 Mediated Live-Cell RNA Imaging and Detection of RNA-Protein Interactions. | Front Cell Dev Biol | 2022 | 35356276 | PubTator, text mining | PubMed |
| The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma. | Front Immunol | 2022 | 35355983 | PubTator, text mining | PubMed |
| Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. | Semin Cancer Biol | 2022 | 35346803 | PubTator, text mining | PubMed |
| Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment. | Semin Cancer Biol | 2022 | 35346801 | PubTator, text mining | PubMed |
| Identified human breast milk compositions effectively inhibit SARS-CoV-2 and variants infection and replication. | iScience | 2022 | 35342878 | PubTator, text mining | PubMed |
| Integration of Multimodal Data from Disparate Sources for Identifying Disease Subtypes. | Biology (Basel) | 2022 | 35336734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=55